(Q79919466)

English

Development of novel agents for the treatment of chronic hepatitis C infection: Summary of the FDA Antiviral Products Advisory Committee recommendations

scientific article published on 01 December 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18027878%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Development of novel agents for the treatment of chronic hepatitis C infection: Summary of the FDA Antiviral Products Advisory Committee recommendations (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18027878%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

chronic hepatitis C

1 reference

based on heuristic

inferred from title

chronic hepatitis

1 reference

based on heuristic

inferred from title

author name string

Kenneth E Sherman

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18027878%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Russell Fleischer

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18027878%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Katherine Laessig

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18027878%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Jeffrey Murray

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18027878%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

William Tauber

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18027878%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Debra Birnkrant

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18027878%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

FDA Antiviral Products Advisory Committee

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18027878%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

language of work or name

0 references

publication date

1 December 2007

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18027878%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18027878%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

46

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18027878%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18027878%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

2014-2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18027878%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

New therapies on the horizon for hepatitis C: are we close?

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21985

7 January 2021

based on heuristic

inferred from DOI database lookup

The extrahepatic contribution to HCV plasma viremia

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21985

7 January 2021

based on heuristic

inferred from DOI database lookup

Rapid production and clearance of HIV-1 and hepatitis C virus assessed by large volume plasma apheresis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21985

7 January 2021

based on heuristic

inferred from DOI database lookup

Discovery of small-molecule inhibitors of HCV NS3-4A protease as potential therapeutic agents against HCV infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21985

7 January 2021

based on heuristic

inferred from DOI database lookup

The natural history of hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21985

7 January 2021

based on heuristic

inferred from DOI database lookup

Estimating future hepatitis C morbidity, mortality, and costs in the United States

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21985

7 January 2021

based on heuristic

inferred from DOI database lookup

Projecting future complications of chronic hepatitis C in the United States

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21985

7 January 2021

based on heuristic

inferred from DOI database lookup

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21985

7 January 2021

based on heuristic

inferred from DOI database lookup

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21985

7 January 2021

based on heuristic

inferred from DOI database lookup

Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21985

7 January 2021

based on heuristic

inferred from DOI database lookup

Sustained virological response to interferon-alpha is associated with improved outcome in HCV-related cirrhosis: a retrospective study

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21985

7 January 2021

based on heuristic

inferred from DOI database lookup

Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21985

7 January 2021

based on heuristic

inferred from DOI database lookup

Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21985

7 January 2021

based on heuristic

inferred from DOI database lookup

Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21985

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatitis C virus superinfection in hepatitis B virus chronic carriers: a reciprocal viral interaction and a variable clinical course

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21985

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatitis C virus superinfection in patients with chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21985

7 January 2021

based on heuristic

inferred from DOI database lookup

Lamivudine treatment is beneficial in patients with severely decompensated cirrhosis and actively replicating hepatitis B infection awaiting liver transplantation: a comparative study using a matched, untreated cohort

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21985

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of advanced hepatitis C with a low accelerating dosage regimen of antiviral therapy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21985

7 January 2021

based on heuristic

inferred from DOI database lookup

The prevalence of hepatitis C virus infection in the United States, 1999 through 2002

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21985

7 January 2021

based on heuristic

inferred from DOI database lookup

Peginterferon and ribavirin treatment in African American and Caucasian American patients with hepatitis C genotype 1.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21985

7 January 2021

based on heuristic

inferred from DOI database lookup

Peginterferon alfa-2b and ribavirin for the treatment of chronic hepatitis C in blacks and non-Hispanic whites

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21985

7 January 2021

based on heuristic

inferred from DOI database lookup

Adherence to combination therapy enhances sustained response in genotype-1-infected patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21985

7 January 2021

based on heuristic

inferred from DOI database lookup

Histological grading and staging of chronic hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21985

7 January 2021

based on heuristic

inferred from DOI database lookup

Model for end-stage liver disease (MELD) and allocation of donor livers

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21985

7 January 2021

based on heuristic

inferred from DOI database lookup

Ribavirin dose modification based on renal function is necessary to reduce hemolysis in liver transplant patients with hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.21985

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/HEP.21985

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18027878%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18027878%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q79919466&oldid=1749920656"